Global Angioplasty Balloons and Stents Market is expected to reach US$ 15,189.2 Mn in 2031 with a growth rate of 5.8%. The Angioplasty Balloons and Stents market falls under the medical devices industry. Angioplasty is a procedure used to open narrowed or blocked blood vessels in the body, typically in the heart. During the procedure, a small balloon-tipped catheter is inserted into the blocked artery and inflated to widen the passage and improve blood flow. Stents, which are small, expandable tubes, are often placed during the procedure to help keep the artery open.

The rising prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is a significant driver fueling the demand for Angioplasty Balloons and Stents. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths in 2019. The growing incidence of these conditions has led to an increased need for effective treatment options, driving the growth of the Angioplasty Balloons and Stents market.

The Angioplasty Balloons And Stents market falls under the medical devices industry. Angioplasty is a procedure used to open narrowed or blocked blood vessels in the body, typically in the heart. During the procedure, a small balloon-tipped catheter is inserted into the blocked artery and inflated to widen the passage and improve blood flow. Stents, which are small, expandable tubes, are often placed during the procedure to help keep the artery open.

Key Report Insights:

Major Market Driver: Increasing prevalence of cardiovascular diseases - According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths in 2019. The rising incidence of conditions like coronary artery disease, which can lead to blocked arteries, is driving demand for angioplasty and related devices.

Companies in the Market: Key players in the Angioplasty Balloons And Stents market are focused on R&D to develop innovative products. For example, Abbott Laboratories has a robust pipeline of next-generation drug-eluting stents and bioresorbable vascular scaffolds. Medtronic plc has also made advancements in its stent technologies, including the Resolute Onyx drug-eluting stent.

Advancements in Diagnostics and Medical Technology: Improvements in imaging techniques like intravascular ultrasound and optical coherence tomography have enhanced the ability to accurately diagnose and assess the severity of arterial blockages. Additionally, the development of drug-eluting balloons and bioresorbable stents represent technological advancements that are transforming the angioplasty market.

Market Growth, Market Dynamics, Market Opportunity Assessment

The Angioplasty Balloons and Stents market is expected to experience robust growth over the forecast period, driven by the rising prevalence of cardiovascular diseases, the advancements in medical technology, and the growing preference for minimally invasive procedures. The market is projected to reach a valuation of US$ 15,189.2 million by 2031, growing at a CAGR of 5.8% from 2024 to 2031.

The market is also witnessing significant opportunities in emerging markets, particularly in the Asia-Pacific region. As healthcare infrastructure improves and the prevalence of cardiovascular diseases increases in these regions, the demand for advanced medical technologies like Angioplasty Balloons and Stents is expected to surge. Manufacturers can capitalize on this opportunity by expanding their sales and distribution networks, tailoring their product offerings to meet the specific needs of these markets, and collaborating with local healthcare providers to improve access to care.

Additionally, the integration of digital technologies, such as artificial intelligence (AI) and machine learning, presents a promising opportunity for the Angioplasty Balloons and Stents market. These advanced technologies can be leveraged to enhance the accuracy of diagnostic imaging, optimize treatment planning, and improve patient monitoring and outcomes, driving further growth in the market.

Market Drivers and Opportunities:

Drivers:

• Rising Prevalence of Cardiovascular Diseases: The growing incidence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is a significant driver fueling the demand for Angioplasty Balloons and Stents. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths in 2019.
• Technological Advancements in Angioplasty Devices: The rapid pace of technological innovation in the medical device industry has been a key driver of the Angioplasty Balloons and Stents market. Manufacturers are continuously investing in research and development to introduce novel products that enhance clinical outcomes and improve patient experiences, such as drug-eluting balloons and bioresorbable stents.

Trends:

• Focus on Personalized and Precision Medicine: The Angioplasty Balloons and Stents market is witnessing a growing trend towards personalized and precision medicine, where treatment strategies are tailored to the unique needs and characteristics of individual patients.
• Emphasis on Minimally Invasive Procedures: The growing preference for minimally invasive medical procedures is a dominant trend in the Angioplasty Balloons and Stents market, as patients and healthcare providers favor options that offer reduced recovery times, lower risks of complications, and improved cosmetic outcomes.

Opportunity:

Emerging Markets in Developing Countries: The Angioplasty Balloons and Stents market presents significant growth opportunities in emerging markets, particularly in developing countries. As healthcare infrastructure improves and the prevalence of cardiovascular diseases increases in these regions, the demand for advanced medical technologies like Angioplasty Balloons and Stents is expected to surge.

Key Regional Insights:

• North America is the Largest Region: North America is expected to be the largest market for Angioplasty Balloons and Stents, accounting for over 43.8% of the global market share in 2024. The growth of the market in North America is attributed to the high prevalence of cardiovascular diseases, the presence of a well-established healthcare infrastructure, and the availability of advanced medical technologies. Key players with a strong presence in the North American market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation.
• Europe is the Second-Largest Region: The European market is the second-largest, representing 31.2% of the global market share in 2024. The growth of the market in Europe is driven by factors such as the aging population, the increasing incidence of lifestyle-related diseases, and the rising awareness of the importance of early diagnosis and treatment. Major companies operating in the European market include Terumo Corporation, B. Braun Melsungen AG, Biotronik SE & Co. KG.
• Prominent Companies in the Market: Some of the prominent companies operating in the Angioplasty Balloons and Stents market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cordis (a Cardinal Health company), Terumo Corporation, B. Braun Melsungen AG, Biotronik SE & Co. KG, Cook Medical, Meril Life Sciences Pvt. Ltd., and Biosensors International Group, Ltd., among others. These companies are leading the market through their innovative product offerings, extensive research and development efforts, and strategic partnerships and acquisitions.

Market Segmentation:

• By Product Type
  • Angioplasty Balloons
    • Plain Old Balloon Angioplasty (POBA) Balloons
    • Drug-Eluting Balloons
    • Cutting/Scoring Balloons
    • Others (e.g., Specialty Balloons)
  • Coronary Stents
    • Bare-Metal Stents
    • Drug-Eluting Stents
    • Bioresorbable Stents
    • Peripheral Stents
    • Nitinol Stents
    • Balloon-Expandable Stents
    • Others (e.g., Covered Stents)
• By End-User
  • Hospitals
  • Cardiac Catheterization Laboratories
  • Ambulatory Surgical Centers
  • Others (e.g., Private Clinics)
• By Material
  • Metallic
    • Stainless Steel
    • Cobalt-Chromium
    • Platinum-Chromium
  • Polymer
    • Polyethylene Terephthalate (PET)
    • Polyurethane
    • Others (e.g., Nylon, PEBAX)
• By Coating
  • Drug-Eluting
    • Paclitaxel-Eluting
    • Sirolimus-Eluting
    • Everolimus-Eluting
  • Non-Drug-Eluting
    • Heparin-Coated
    • Hydroxy-Apatite Coated
    • Others (e.g., Polyzene-F Coated)
• By Application
  • Coronary Artery Disease
  • Peripheral Artery Disease
  • Carotid Artery Disease
  • Others (e.g., Renal Artery Disease)
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Definition:

“The Angioplasty Balloons and Stents market refers to the industry that manufactures and distributes medical devices used in the treatment of blocked or narrowed blood vessels, typically in the heart. Angioplasty is a procedure where a small balloon-tipped catheter is inserted into the blocked artery and inflated to widen the passage and improve blood flow. Stents, which are small, expandable tubes, are often placed during the procedure to help keep the artery open and prevent it from closing again. These devices are essential for the treatment of cardiovascular diseases, such as coronary artery disease, and are widely used in both surgical and minimally invasive medical procedures.”